Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 17,700 | $0.00 Strike: $26.02 | $0.00 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · derivative · entry 17 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 17,700 shares Expires 2019-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 33,900 | $0.00 Strike: $26.70 | $0.00 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · derivative · entry 16 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 33,900 shares Expires 2018-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 1,400 | $44.09 | $61,727.40 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · nonDerivative · entry 11 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,136 Read SEC document |
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 255 | $44.09 | $11,242.95 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · nonDerivative · entry 10 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,536 Read SEC document |
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 1,064 | $44.08 | $46,901.12 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · nonDerivative · entry 9 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,791 Read SEC document |
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 300 | $44.07 | $13,221.90 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · nonDerivative · entry 8 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,855 Read SEC document |
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 200 | $44.07 | $8,814.40 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · nonDerivative · entry 7 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,155 Read SEC document |
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 35,607 | $44.07 | $1,569,236.10 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · nonDerivative · entry 6 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,355 Read SEC document |
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 11,374 | $44.07 | $501,252.18 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · nonDerivative · entry 5 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,962 Read SEC document |
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 300 | $44.06 | $13,218.30 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · nonDerivative · entry 4 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,336 Read SEC document |
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 1,100 | $44.06 | $48,466.00 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · nonDerivative · entry 3 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,636 Read SEC document |
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionCommon shares without par value | 17,700 | $26.02 | $460,465.50 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · nonDerivative · entry 2 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2014 Filed Nov 26, 2014 22:06 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionCommon shares without par value | 33,900 | $26.70 | $905,038.47 |
DisclosureSEC source: 0001179110-14-017222 · edgar.xml · nonDerivative · entry 1 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2014 Filed Nov 12, 2014 23:54 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,200 | $0.00 Strike: $26.70 | $0.00 |
DisclosureSEC source: 0001179110-14-016462 · edgar.xml · derivative · entry 13 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common shares · 3,200 shares Expires 2018-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 10, 2014 Filed Nov 12, 2014 23:54 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,100 | $0.00 Strike: $25.76 | $0.00 |
DisclosureSEC source: 0001179110-14-016462 · edgar.xml · derivative · entry 12 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common shares · 3,100 shares Expires 2017-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| November 10, 2014 Filed Nov 12, 2014 23:54 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 1,100 | $43.69 | $48,055.70 |
DisclosureSEC source: 0001179110-14-016462 · edgar.xml · nonDerivative · entry 10 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 2,046 Read SEC document |
| November 10, 2014 Filed Nov 12, 2014 23:54 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 400 | $43.69 | $17,474.00 |
DisclosureSEC source: 0001179110-14-016462 · edgar.xml · nonDerivative · entry 9 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,146 Read SEC document |
| November 10, 2014 Filed Nov 12, 2014 23:54 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 600 | $43.68 | $26,209.80 |
DisclosureSEC source: 0001179110-14-016462 · edgar.xml · nonDerivative · entry 8 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 3,546 Read SEC document |
| November 10, 2014 Filed Nov 12, 2014 23:54 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 4,200 | $43.68 | $183,460.20 |
DisclosureSEC source: 0001179110-14-016462 · edgar.xml · nonDerivative · entry 7 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 4,146 Read SEC document |
| November 10, 2014 Filed Nov 12, 2014 23:54 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,200 | $26.70 | $85,431.36 |
DisclosureSEC source: 0001179110-14-016462 · edgar.xml · nonDerivative · entry 6 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 8,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 10, 2014 Filed Nov 12, 2014 23:54 UTC |
Contreras JaimeSenior Vice President
|
Exercise / conversionCommon shares without par value | 3,100 | $25.76 | $79,842.05 |
DisclosureSEC source: 0001179110-14-016462 · edgar.xml · nonDerivative · entry 5 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 5,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2014 Filed Oct 30, 2014 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 38,034 | $0.00 Strike: $22.27 | $0.00 |
DisclosureSEC source: 0001179110-14-015890 · edgar.xml · derivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 38,034 shares Expires 2015-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 29, 2014 Filed Oct 30, 2014 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 38,034 | $42.70 | $1,624,051.80 |
DisclosureSEC source: 0001179110-14-015890 · edgar.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,414,525 Read SEC document |
| October 29, 2014 Filed Oct 30, 2014 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 38,034 | $22.27 | $846,903.08 |
DisclosureSEC source: 0001179110-14-015890 · edgar.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,452,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2014 Filed Oct 30, 2014 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 402,766 | $0.00 Strike: $22.27 | $0.00 |
DisclosureSEC source: 0001179110-14-015890 · edgar.xml · derivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,876 Underlying: Common shares · 402,766 shares Expires 2015-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| October 28, 2014 Filed Oct 30, 2014 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 384,107 | $42.50 | $16,324,547.50 |
DisclosureSEC source: 0001179110-14-015890 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,414,525 Read SEC document |
| October 28, 2014 Filed Oct 30, 2014 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 5,700 | $42.50 | $242,264.25 |
DisclosureSEC source: 0001179110-14-015890 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,798,632 Read SEC document |
| October 28, 2014 Filed Oct 30, 2014 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 12,959 | $42.51 | $550,822.30 |
DisclosureSEC source: 0001179110-14-015890 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,804,332 Read SEC document |
| October 28, 2014 Filed Oct 30, 2014 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 402,766 | $22.27 | $8,968,390.52 |
DisclosureSEC source: 0001179110-14-015890 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,817,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 30, 2014 Filed Oct 1, 2014 21:09 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 189 | $41.59 Strike: $0.00 | $7,860.51 |
DisclosureSEC source: 0001179110-14-014730 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002 Underlying: Common shares · 189 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2014 Filed Oct 1, 2014 21:10 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 793 | $41.59 Strike: $0.00 | $32,980.87 |
DisclosureSEC source: 0001179110-14-014731 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,358 Underlying: Common shares · 793 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2014 Filed Oct 1, 2014 21:10 UTC |
OSBORN WILLIAM ADirector
|
GrantStock Equivalent Units · Derivative | 829 | $41.59 Strike: $0.00 | $34,478.11 |
DisclosureSEC source: 0001179110-14-014732 · edgar.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,274 Underlying: Common shares · 829 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2014 Filed Oct 1, 2014 21:11 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 793 | $41.59 Strike: $0.00 | $32,980.87 |
DisclosureSEC source: 0001179110-14-014733 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,185 Underlying: Common shares · 793 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2014 Filed Nov 12, 2014 23:54 UTC |
Contreras JaimeSenior Vice President
|
OtherCommon shares without par value | 16 | $41.75 | $668.05 |
DisclosureSEC source: 0001179110-14-016462 · edgar.xml · nonDerivative · entry 3 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · Profit Sharing Trust (by spouse) Disclosed balance after: 0 F1 · balance_after: Balance in the Abbott Laboratories Stock Retirement Trust as of November 10, 2014. Read SEC document |
| September 26, 2014 Filed Sep 30, 2014 21:05 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
GrantOption (right to buy) · Derivative | 102,425 | $0.00 Strike: $42.08 | $0.00 |
DisclosureSEC source: 0001179110-14-014651 · edgar.xml · derivative · entry 3 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,425 Underlying: Common shares · 102,425 shares Expires 2024-09-25 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 34,142 on 9/26/2015, 34,141 on 9/26/2016, and 34,142 on 9/26/2017. Read SEC document |
| September 26, 2014 Filed Sep 30, 2014 21:05 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
GrantCommon shares without par value | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-014651 · edgar.xml · nonDerivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,230 F2 · shares: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| September 26, 2014 Filed Sep 30, 2014 21:05 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
GrantCommon shares without par value | 16,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-014651 · edgar.xml · nonDerivative · entry 1 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,730 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| September 18, 2014 Filed Sep 19, 2014 21:10 UTC |
Fussell Stephen RExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 17,400 | $0.00 Strike: $23.22 | $0.00 |
DisclosureSEC source: 0001179110-14-014360 · edgar.xml · derivative · entry 7 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 17,400 shares Expires 2015-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 18, 2014 Filed Sep 19, 2014 21:10 UTC |
Fussell Stephen RExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 14,500 | $0.00 Strike: $22.27 | $0.00 |
DisclosureSEC source: 0001179110-14-014360 · edgar.xml · derivative · entry 6 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 14,500 shares Expires 2015-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| September 18, 2014 Filed Sep 19, 2014 21:10 UTC |
Fussell Stephen RExecutive Vice President
|
Tax withholdingCommon shares without par value | 23,619 | $43.38 | $1,024,592.22 |
DisclosureSEC source: 0001179110-14-014360 · edgar.xml · nonDerivative · entry 3 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,045 Read SEC document |
| September 18, 2014 Filed Sep 19, 2014 21:10 UTC |
Fussell Stephen RExecutive Vice President
|
Exercise / conversionCommon shares without par value | 17,400 | $23.22 | $404,000.16 |
DisclosureSEC source: 0001179110-14-014360 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2014 Filed Sep 19, 2014 21:10 UTC |
Fussell Stephen RExecutive Vice President
|
Exercise / conversionCommon shares without par value | 14,500 | $22.27 | $322,871.50 |
DisclosureSEC source: 0001179110-14-014360 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2014 Filed Jul 22, 2014 21:03 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 56,000 | $0.00 Strike: $25.25 | $0.00 |
DisclosureSEC source: 0001179110-14-011914 · edgar.xml · derivative · entry 11 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Common shares · 56,000 shares Expires 2017-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 21, 2014 Filed Jul 22, 2014 21:03 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 23,000 | $0.00 Strike: $21.22 | $0.00 |
DisclosureSEC source: 0001179110-14-011914 · edgar.xml · derivative · entry 10 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 23,000 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 21, 2014 Filed Jul 22, 2014 21:03 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 60,702 | $42.73 | $2,593,796.46 |
DisclosureSEC source: 0001179110-14-011914 · edgar.xml · nonDerivative · entry 3 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,624 Read SEC document |
| July 21, 2014 Filed Jul 22, 2014 21:03 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 56,000 | $25.25 | $1,413,781.60 |
DisclosureSEC source: 0001179110-14-011914 · edgar.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 21, 2014 Filed Jul 22, 2014 21:03 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 23,000 | $21.22 | $488,046.20 |
DisclosureSEC source: 0001179110-14-011914 · edgar.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2014 Filed Jul 2, 2014 21:13 UTC |
DeVos Georges H.Senior Vice President
|
GrantCommon shares without par value | 7,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-011326 · edgar.xml · nonDerivative · entry 1 DeVos Georges H. · CIK 0001580246 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,667 F1 · shares: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| July 01, 2014 Filed Jul 2, 2014 21:13 UTC |
Pavee Jean-YvesSenior Vice President
|
Tax withholdingCommon shares without par value | 1,840 | $40.90 | $75,256.00 |
DisclosureSEC source: 0001179110-14-011330 · edgar.xml · nonDerivative · entry 2 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,716 Read SEC document |
| July 01, 2014 Filed Jul 2, 2014 21:13 UTC |
Pavee Jean-YvesSenior Vice President
|
GrantCommon shares without par value | 6,077 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-14-011330 · edgar.xml · nonDerivative · entry 1 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,556 F1 · shares: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.